1	An	an	DT	_	2	det	_
2	error	error	NN	_	4	nsubj	4:A1=PPT
3	has	have	VBZ	_	4	aux	_
4	occured	occur	VBN	pb=occur.01	0	root	_
5	and	and	CC	_	4	cc	_
6	your	your	PRP$	_	7	poss	_
7	email	email	NN	_	11	nsubjpass	11:A1=PPT
8	has	have	VBZ	_	11	aux	_
9	not	not	RB	_	11	neg	11:AM-NEG
10	been	be	VBN	_	11	auxpass	_
11	sent	send	VBN	pb=send.01	4	conj	_
12	.	.	.	_	11	punct	_

1	•	•	NFP	p2=JJ	2	punct	_
2	Seperate	seperate	VB	pb=seperate.01	0	root	_
3	multiple	multiple	JJ	_	4	amod	_
4	addresses	address	NNS	_	2	dobj	2:A1
5	with	with	IN	_	2	prep	2:A2
6	Commas	commas	NNP	p2=NNS	5	pobj	_
7	.	.	.	_	2	punct	_

1	•	•	:	p2=,	3	punct	_
2	Must	must	MD	_	3	aux	3:AM-MOD
3	enter	enter	VB	pb=enter.01	0	root	_
4	an	an	DT	_	6	det	_
5	email	email	NN	_	6	nn	_
6	address	address	NN	_	3	dobj	3:A1=LOC
7	.	.	.	_	3	punct	_

1	•	•	``	p2=UH	4	punct	_
2	You	you	PRP	_	4	nsubj	4:A0=PPT;10:A0=PAG
3	must	must	MD	_	4	aux	4:AM-MOD
4	enter	enter	VB	pb=enter.01	0	root	_
5	the	the	DT	_	7	det	_
6	verification	verification	NN	_	7	nn	_
7	code	code	NN	_	4	dobj	4:A1=LOC
8	below	below	RB	p2=IN	4	advmod	4:AM-MNR
9	to	to	TO	_	10	aux	_
10	send	send	VB	pb=send.01	4	advcl	4:AM-PRP
11	.	.	.	_	4	punct	_

1	•	•	HYPH	p2=``	2	nn	_
2	Invalid	invalid	NNP	p2=JJ	3	nn	_
3	entry	entry	NN	_	6	dep	_
4	:	:	:	_	6	punct	_
5	Please	please	UH	p2=VB	6	intj	6:AM-DIS
6	type	type	VB	pb=type.01	0	root	_
7	the	the	DT	_	9	det	_
8	verification	verification	NN	_	9	nn	_
9	code	code	NN	_	6	dobj	6:A1=PPT
10	again	again	RB	_	6	advmod	6:AM-TMP
11	.	.	.	_	6	punct	_

1	LONDON	london	NNP	_	6	nsubj	6:A0=PAG
2	--	--	:	p2=.	1	punct	_
3	AstraZeneca	astrazeneca	NNP	_	4	nn	_
4	PLC	plc	NNP	_	5	nn	_
5	Monday	monday	NNP	_	1	appos	_
6	rejected	reject	VBD	pb=reject.01	0	root	_
7	what	what	WP	_	11	dobj	_
8	U.S.	u.s.	NNP	_	11	nn	_
9	peer	peer	NN	p2=VB	11	nn	_
10	Pfizer	pfizer	NNP	_	11	nn	_
11	Inc	inc	NNP	_	6	dobj	6:A1=PPT
12	.	.	.	_	6	punct	_

1	said	say	VBD	pb=say.01	0	root	_
2	was	be	VBD	_	8	aux	_
3	its	its	PRP$	_	6	poss	_
4	final	final	JJ	_	6	amod	_
5	increased	increase	VBN	p2=VBN|pb=increase.01	6	amod	_
6	offer	offer	NN	p2=VB	8	attr	5:A1=PPT;8:A1=PPT
7	,	,	,	_	6	punct	_
8	seeming	seem	VBG	pb=seem.01	1	ccomp	1:A1=PPT
9	to	to	TO	p2=IN	10	aux	_
10	scuttle	scuttle	VB	pb=scuttle.01	8	xcomp	8:C-A1
11	what	what	WP	_	14	nsubj	14:R-A1
12	would	would	MD	_	14	aux	14:AM-MOD
13	have	have	VB	_	14	aux	_
14	been	be	VBN	pb=be.01	10	ccomp	10:A1=PPT
15	a	a	DT	_	17	det	_
16	huge	huge	JJ	_	17	amod	_
17	trans	trans	NNS	p2=NN	14	attr	14:A2=PRD
18	-	-	:	p2=,	17	punct	_
19	Atlantic	atlantic	NNP	p2=JJ	21	nn	_
20	pharmaceutical	pharmaceutical	NN	p2=JJ	21	nn	_
21	merger	merger	NN	_	17	appos	_
22	.	.	.	_	1	punct	_

1	Late	late	NNP	p2=JJ	2	amod	_
2	Sunday	sunday	NNP	_	5	npadvmod	5:AM-TMP
3	,	,	,	_	5	punct	_
4	Pfizer	pfizer	NNP	_	5	nsubj	5:A0
5	made	make	VBD	pb=make.LV	0	root	_
6	a	a	DT	_	8	det	_
7	final	final	JJ	_	8	amod	_
8	offer	offer	NN	_	5	dobj	11:A1;5:AM-PRR
9	for	for	IN	_	8	prep	_
10	AstraZeneca	astrazeneca	NNP	_	9	pobj	_
11	valued	value	VBN	p2=VBD|pb=value.01	8	partmod	_
12	at	at	IN	_	11	prep	11:A2=PRD
13	about	about	IN	_	16	quantmod	_
14	$	$	$	_	16	quantmod	_
15	120	0	CD	_	16	number	_
16	billion	#crd#	CD	_	12	pobj	_
17	,	,	,	_	16	punct	_
18	or	or	CC	_	16	cc	_
19	GBP	gbp	NNP	p2=$	39	npadvmod	_
20	55	0	CD	_	19	num	_
21	(	(	-LRB-	_	23	punct	_
22	$	$	$	_	23	nmod	_
23	92.51	0	CD	_	19	appos	_
24	)	)	-RRB-	_	23	punct	_
25	a	a	DT	_	26	det	_
26	share	share	NN	_	23	npadvmod	_
27	with	with	IN	_	26	prep	_
28	a	a	DT	_	32	det	_
29	45	0	CD	_	30	num	_
30	%	%	NN	_	32	nn	_
31	cash	cash	NN	_	32	nn	_
32	component	component	NN	_	27	pobj	_
33	,	,	,	_	19	punct	_
34	after	after	IN	_	39	mark	_
35	the	the	DT	_	38	det	_
36	British	british	JJ	_	38	amod	_
37	pharmaceutical	pharmaceutical	JJ	p2=NN	38	amod	_
38	company	company	NN	_	39	nsubj	39:A0=PAG;44:A0=PPT
39	rebuffed	rebuff	VBD	pb=rebuff.01	5	advcl	5:AM-TMP
40	its	its	PRP$	_	42	poss	_
41	latest	late	JJS	_	42	amod	_
42	effort	effort	NN	_	39	dobj	39:A1=PPT
43	to	to	TO	_	44	aux	_
44	enter	enter	VB	pb=enter.01	42	infmod	_
45	takeover	takeover	NN	_	46	nn	_
46	talks	talk	NNS	_	44	dobj	44:A1=LOC
47	.	.	.	_	5	punct	_

1	AstraZeneca	astrazeneca	NNP	_	2	nsubj	2:A0
2	said	say	VBD	pb=say.01	0	root	_
3	it	it	PRP	_	4	nsubj	4:A0=PAG
4	made	make	VBD	pb=make.02	2	ccomp	2:A1=PPT
5	clear	clear	JJ	_	4	ccomp	4:A1=PRD
6	on	on	IN	_	5	prep	_
7	a	a	DT	_	9	det	_
8	phone	phone	NN	_	9	nn	_
9	call	call	NN	_	6	pobj	_
10	to	to	IN	_	9	prep	_
11	Pfizer	pfizer	NNP	_	13	nn	_
12	Sunday	sunday	NNP	_	13	nn	_
13	afternoon	afternoon	NN	_	10	pobj	_
14	that	that	IN	p2=WDT	42	complm	_
15	an	an	DT	_	16	det	_
16	offer	offer	NN	p2=VBP	42	nsubjpass	26:A1=PPT;31:A1=PPT;42:A1=PPT
17	more	more	JJR	p2=RBR	19	amod	_
18	than	than	IN	_	19	quantmod	_
19	10	0	CD	_	20	num	_
20	%	%	NN	_	21	npadvmod	_
21	above	above	IN	_	16	prep	_
22	the	the	DT	_	25	det	_
23	GBP	gbp	NNP	_	25	nn	_
24	53.50	0	CD	p2=NNP	25	num	_
25	Pfizer	pfizer	NNP	_	21	pobj	_
26	offered	offer	VBD	p2=VBN|pb=offer.01	16	partmod	_
27	Friday	friday	NNP	_	26	npadvmod	26:AM-TMP
28	--	--	:	_	16	punct	_
29	which	which	WDT	_	31	nsubj	31:R-A0
30	would	would	MD	_	31	aux	31:AM-MOD
31	equate	equate	VB	pb=equate.01	16	rcmod	_
32	to	to	IN	_	31	prep	31:A2=PPT
33	a	a	DT	_	34	det	_
34	figure	figure	NN	_	32	pobj	_
35	greater	great	JJR	_	34	amod	_
36	than	than	IN	_	35	prep	_
37	GBP	gbp	NNP	_	36	pobj	_
38	58.85	0	CD	_	37	num	_
39	--	--	:	_	42	punct	_
40	would	would	MD	_	42	aux	42:AM-MOD
41	be	be	VB	_	42	auxpass	_
42	needed	need	VBN	pb=need.01	4	ccomp	_
43	to	to	TO	_	44	aux	_
44	secure	secure	VB	pb=secure.01	42	advcl	42:AM-PRP
45	the	the	DT	_	46	det	_
46	board	board	NN	_	48	poss	_
47	's	's	POS	_	46	possessive	_
48	recommendation	recommendation	NN	_	44	dobj	44:A1=PPT
49	.	.	.	_	2	punct	_

1	A	a	DT	_	3	det	_
2	few	few	JJ	_	3	amod	_
3	hours	hour	NNS	_	4	npadvmod	_
4	later	late	RBR	p2=RB	7	advmod	7:AM-TMP
5	,	,	,	_	7	punct	_
6	Pfizer	pfizer	NNP	p2=NN	7	nsubj	7:A1=PPT
7	came	come	VBD	pb=come.01	0	root	_
8	back	back	RB	_	7	advmod	7:AM-DIR
9	with	with	IN	_	7	prep	7:A3=DIR
10	its	its	PRP$	_	14	poss	_
11	"	"	``	_	14	punct	_
12	final	final	JJ	_	14	amod	_
13	"	"	''	p2=NNS	14	punct	_
14	offer	offer	NN	p2=VBP	9	pobj	_
15	of	of	IN	_	14	prep	_
16	GBP	gbp	NNP	_	15	pobj	_
17	55	0	CD	_	16	num	_
18	a	a	DT	_	19	det	_
19	share	share	NN	_	17	npadvmod	_
20	.	.	.	_	7	punct	_

1	While	while	IN	_	4	mark	_
2	the	the	DT	_	3	det	_
3	rejection	rejection	NN	_	4	nsubj	4:A1=PPT
4	is	be	VBZ	pb=be.01	0	root	_
5	a	a	DT	_	9	det	_
6	near	near	JJ	p2=RB	8	hmod	_
7	-	-	HYPH	_	8	hyph	_
8	fatal	fatal	JJ	p2=NN	9	amod	_
9	setback	setback	NN	_	4	attr	4:A2=PRD
10	in	in	IN	_	9	prep	_
11	any	any	DT	_	13	det	_
12	potential	potential	JJ	_	13	amod	_
13	deal	deal	NN	_	10	pobj	_
14	between	between	IN	_	13	prep	_
15	the	the	DT	_	18	det	_
16	two	#crd#	CD	_	18	num	_
17	drug	drug	NN	_	18	nn	_
18	giants	giant	NNS	_	14	pobj	23:A1=PPT
19	,	,	,	_	18	punct	_
20	U.K.	u.k.	NNP	_	22	nn	_
21	takeover	takeover	NN	_	22	nn	_
22	rules	rule	NNS	_	23	nsubj	23:A0=PAG
23	give	give	VBP	pb=give.01	18	rcmod	_
24	Pfizer	pfizer	NNP	_	23	dobj	23:A2=GOL
25	and	and	CC	_	24	cc	_
26	AstraZeneca	astrazeneca	NNP	_	24	conj	_
27	until	until	IN	_	23	prep	23:AM-TMP
28	May	may	NNP	_	27	pobj	_
29	26	0	CD	_	28	num	_
30	--	--	:	_	18	punct	_
31	four	#crd#	CD	_	32	num	_
32	weeks	week	NNS	_	18	appos	_
33	from	from	IN	_	32	prep	_
34	the	the	DT	_	35	det	_
35	confirmation	confirmation	NN	_	33	pobj	_
36	of	of	IN	_	35	prep	_
37	Pfizer	pfizer	NNP	p2=NN	40	poss	_
38	's	's	POS	_	37	possessive	_
39	earlier	early	JJR	p2=RBR	40	amod	_
40	approach	approach	NN	_	36	pobj	_
41	--	--	:	_	18	punct	_
42	to	to	TO	_	43	aux	_
43	enter	enter	VB	pb=enter.01	9	infmod	_
44	takeover	takeover	NN	_	45	nn	_
45	discussions	discussion	NNS	_	43	dobj	43:A1=LOC
46	.	.	.	_	4	punct	_

1	That	that	DT	p2=WDT	2	nsubj	2:A0=PAG
2	allows	allow	VBZ	pb=allow.01	0	root	_
3	time	time	NN	_	2	dobj	2:A1=PPT
4	for	for	IN	_	3	prep	_
5	any	any	DT	_	6	det	_
6	investors	investor	NNS	_	4	pobj	7:A1=PPT
7	dismayed	dismay	VBN	p2=VBD|pb=dismay.01	6	partmod	_
8	with	with	IN	_	7	prep	7:A2=CAU
9	AstraZeneca	astrazeneca	NNP	_	14	poss	_
10	's	's	POS	_	9	possessive	_
11	12	0	CD	_	12	num	_
12	%	%	NN	_	14	nn	_
13	share-price	share-price	NN	p2=NNS	14	nn	_
14	fall	fall	NN	p2=VBP	8	pobj	_
15	Monday	monday	NNP	p2=NN	14	npadvmod	_
16	to	to	TO	_	17	aux	_
17	push	push	VB	pb=push.02	14	infmod	_
18	the	the	DT	_	19	det	_
19	board	board	NN	_	17	dobj	21:A0=PAG;17:A1=PPT
20	to	to	TO	_	21	aux	_
21	engage	engage	VB	pb=engage.01	17	xcomp	17:A2=PRD
22	in	in	IN	_	21	prep	21:A2=PPT
23	talks	talk	NNS	_	22	pobj	_
24	.	.	.	_	2	punct	_

1	Because	because	IN	_	4	mark	_
2	it	it	PRP	_	4	nsubj	4:A0=PAG;7:A0=PAG
3	has	have	VBZ	_	4	aux	_
4	pledged	pledge	VBN	pb=pledge.01	15	advcl	15:AM-CAU
5	not	not	RB	_	7	neg	7:AM-NEG
6	to	to	TO	_	7	aux	_
7	pursue	pursue	VB	pb=pursue.01	4	xcomp	4:A2=PPT
8	a	a	DT	_	10	det	_
9	hostile	hostile	JJ	_	10	amod	_
10	bid	bid	NN	_	7	dobj	7:A1=PPT
11	,	,	,	_	15	punct	_
12	Pfizer	pfizer	NNP	p2=NN	15	nsubj	15:A1=PPT
13	can	can	MD	_	15	aux	15:AM-MOD
14	not	not	RB	_	15	neg	15:AM-NEG
15	come	come	VB	pb=come.01	0	root	_
16	back	back	RB	_	15	advmod	15:AM-DIR
17	with	with	IN	_	15	prep	15:AM-COM
18	an	an	DT	_	19	det	_
19	offer	offer	NN	_	17	pobj	_
20	higher	high	JJR	p2=RBR	19	amod	_
21	than	than	IN	_	20	prep	_
22	GBP	gbp	NNP	_	21	pobj	_
23	55	0	CD	_	22	num	_
24	before	before	IN	_	22	prep	_
25	May	may	NNP	_	24	pobj	_
26	26	0	CD	_	25	num	_
27	.	.	.	_	15	punct	_

1	If	if	IN	_	3	mark	_
2	AstraZeneca	astrazeneca	NNP	_	3	nsubj	5:A0=PAG;3:A1=PPT
3	were	be	VBD	pb=be.01	15	advcl	15:AM-ADV
4	to	to	TO	_	5	aux	_
5	recommend	recommend	VB	pb=recommend.01	3	xcomp	3:A2=PRD
6	the	the	DT	_	8	det	_
7	current	current	JJ	_	8	amod	_
8	bid	bid	NN	_	5	dobj	5:A1=PPT
9	before	before	IN	_	8	prep	_
10	that	that	DT	p2=IN	11	det	_
11	date	date	NN	_	9	pobj	_
12	,	,	,	_	15	punct	_
13	Pfizer	pfizer	NNP	_	15	nsubj	15:A0=PAG
14	could	could	MD	_	15	aux	15:AM-MOD
15	improve	improve	VB	pb=improve.01	0	root	_
16	the	the	DT	_	17	det	_
17	terms	term	NNS	_	15	dobj	15:A1=PPT
18	of	of	IN	_	17	prep	_
19	its	its	PRP$	_	21	poss	_
20	current	current	JJ	_	21	amod	_
21	offer	offer	NN	p2=VBP	18	pobj	_
22	three	#crd#	CD	_	23	num	_
23	months	month	NNS	_	24	npadvmod	_
24	later	later	RB	_	15	advmod	15:AM-TMP
25	,	,	,	_	15	punct	_
26	according	accord	VBG	_	15	prep	15:AM-ADV
27	to	to	IN	_	26	prep	_
28	the	the	DT	_	30	det	_
29	takeover	takeover	NN	_	30	nn	_
30	rules	rule	NNS	_	27	pobj	_
31	.	.	.	_	15	punct	_

1	"	"	``	_	24	punct	_
2	I	I	PRP	_	3	nsubj	3:A0
3	think	think	VBP	pb=think.01	24	ccomp	24:A1=PPT
4	this	this	DT	_	5	det	_
5	rejection	rejection	NN	_	7	nsubj	7:A1=PPT
6	will	will	MD	_	7	aux	7:AM-MOD
7	go	go	VB	pb=go.01	3	ccomp	3:A1=PPT
8	down	down	RP	p2=RB	7	advmod	7:AM-DIR
9	poorly	poorly	RB	_	7	advmod	7:AM-MNR
10	with	with	IN	_	7	prep	7:A2=EXT
11	investors	investor	NNS	_	10	pobj	14:A0=PAG
12	who	who	WP	_	14	nsubj	14:R-A0
13	are	be	VBP	_	14	aux	_
14	urging	urge	VBG	pb=urge.01	11	rcmod	_
15	AZ	az	NNP	_	14	dobj	17:A0=PAG;14:A1=PPT
16	to	to	TO	_	17	aux	_
17	engage	engage	VB	pb=engage.01	14	xcomp	14:A2=PPT
18	with	with	IN	_	17	prep	17:A2=PPT
19	Pfizer	pfizer	NNP	_	18	pobj	_
20	,	,	,	_	24	punct	_
21	"	"	''	p2=``	24	punct	_
22	Credit	credit	NNP	_	23	nn	_
23	Suisse	suisse	NNP	_	24	nsubj	24:A0;32:A0=PAG
24	said	say	VBD	pb=say.01	0	root	_
25	in	in	IN	_	24	prep	24:AM-LOC
26	a	a	DT	_	27	det	_
27	note	note	NN	_	25	pobj	_
28	to	to	IN	_	24	prep	24:A2=GOL
29	clients	client	NNS	_	28	pobj	_
30	Monday	monday	NNP	_	24	npadvmod	24:AM-TMP
31	,	,	,	_	24	punct	_
32	adding	add	VBG	pb=add.01	24	advcl	24:AM-ADV
33	that	that	IN	_	36	complm	_
34	investor	investor	NN	_	35	nn	_
35	feedback	feedback	NN	_	36	nsubj	36:A1=PPT
36	was	be	VBD	pb=be.01	32	ccomp	32:A1=PPT
37	that	that	IN	_	42	complm	_
38	the	the	DT	_	41	det	_
39	GBP	gbp	NNP	_	41	nn	_
40	55	0	CD	_	41	num	_
41	level	level	NN	_	42	nsubj	42:A1=PPT
42	was	be	VBD	pb=be.01	36	ccomp	36:A2=PRD
43	fair	fair	JJ	_	42	acomp	42:A2=PRD
44	.	.	.	_	24	punct	_

1	"	"	``	_	8	punct	_
2	Investor	investor	NN	p2=VB	3	nn	_
3	pressure	pressure	NN	_	8	nsubj	8:A1=PPT
4	on	on	IN	_	3	prep	_
5	AZ	az	NNP	_	4	pobj	_
6	really	really	RB	_	8	advmod	8:AM-ADV
7	now	now	RB	_	8	advmod	8:AM-TMP
8	becomes	become	VBZ	pb=become.01	0	root	_
9	key	key	JJ	p2=NN	8	acomp	8:A2=PRD
10	in	in	IN	_	9	prep	_
11	this	this	DT	_	12	det	_
12	process	process	NN	_	10	pobj	_
13	.	.	.	_	8	punct	_
14	"	"	''	_	8	punct	_

1	One	#crd#	CD	_	5	num	_
2	top	top	JJ	p2=RB	4	hmod	_
3	-	-	HYPH	_	4	hyph	_
4	10	0	CD	_	5	nn	_
5	shareholder	shareholder	NN	_	20	nsubj	9:A0=PAG;20:A0=PPT
6	who	who	WP	_	9	nsubj	9:R-A0
7	had	have	VBD	_	9	aux	_
8	been	be	VBN	_	9	aux	_
9	pushing	push	VBG	pb=push.01	5	rcmod	_
10	last	last	JJ	_	11	amod	_
11	week	week	NN	_	9	npadvmod	9:AM-TMP
12	for	for	IN	_	17	mark	_
13	the	the	DT	_	15	det	_
14	AstraZeneca	astrazeneca	NNP	_	15	nn	_
15	board	board	NN	_	17	nsubj	17:A0=PAG
16	to	to	TO	_	17	aux	_
17	engage	engage	VB	pb=engage.01	9	advcl	_
18	with	with	IN	_	17	prep	17:A2=PPT
19	Pfizer	pfizer	NNP	_	18	pobj	_
20	reacted	react	VBD	pb=react.01	0	root	_
21	with	with	IN	_	20	prep	20:A1=PAG
22	displeasure	displeasure	NN	_	21	pobj	_
23	to	to	IN	_	22	prep	_
24	the	the	DT	_	25	det	_
25	rejection	rejection	NN	_	23	pobj	_
26	.	.	.	_	20	punct	_

1	"	"	``	_	19	punct	_
2	This	this	DT	_	3	nsubj	3:A0=PAG
3	looks	look	VBZ	pb=look.02	19	ccomp	19:A1=PPT
4	to	to	IN	_	3	prep	3:A1=PPT
5	me	me	PRP	_	4	pobj	_
6	like	like	IN	_	3	prep	3:C-V
7	a	a	DT	_	8	det	_
8	case	case	NN	_	6	pobj	_
9	of	of	IN	_	8	prep	_
10	blatant	blatant	JJ	_	11	amod	_
11	disregard	disregard	NN	_	9	pobj	_
12	of	of	IN	_	11	prep	_
13	shareholder	shareholder	NN	_	14	nn	_
14	interest	interest	NN	_	12	pobj	_
15	,	,	,	_	19	punct	_
16	"	"	''	p2=``	19	punct	_
17	the	the	DT	_	18	det	_
18	shareholder	shareholder	NN	_	19	nsubj	19:A0
19	said	say	VBD	pb=say.01	0	root	_
20	.	.	.	_	19	punct	_

1	"	"	``	_	4	punct	_
2	We	we	PRP	_	4	nsubj	4:A0=PAG
3	have	have	VBP	_	4	aux	_
4	engaged	engage	VBN	pb=engage.01	12	ccomp	_
5	deeply	deeply	RB	_	4	advmod	4:AM-MNR
6	with	with	IN	_	4	prep	4:A2=PPT
7	Pfizer	pfizer	NNP	_	6	pobj	_
8	,	,	,	_	12	punct	_
9	we	we	PRP	_	12	nsubj	12:A0=PAG;14:A0=PAG
10	have	have	VBP	_	12	aux	_
11	really	really	RB	_	12	advmod	12:AM-ADV
12	tried	try	VBN	pb=try.01	28	ccomp	28:A1=PPT
13	to	to	TO	_	14	aux	_
14	understand	understand	VB	pb=understand.01	12	xcomp	12:A1=PPT
15	what	what	WP	_	21	attr	21:R-A2
16	the	the	DT	_	17	det	_
17	values	value	NNS	_	21	nsubj	21:A1=PPT
18	for	for	IN	_	17	prep	_
19	our	our	PRP$	_	20	poss	_
20	shareholders	shareholder	NNS	_	18	pobj	_
21	are	be	VBP	pb=be.01	14	ccomp	14:A1=PPT
22	,	,	,	_	28	punct	_
23	"	"	``	p2=''	28	punct	_
24	AstraZeneca	astrazeneca	NNP	_	25	nn	_
25	Chairman	chairman	NNP	_	27	nn	_
26	Leif	leif	NNP	_	27	nn	_
27	Johansson	johansson	NNP	_	28	nsubj	28:A0;39:A0=PAG
28	said	say	VBD	pb=say.01	0	root	_
29	Monday	monday	NNP	_	28	npadvmod	28:AM-TMP
30	in	in	IN	_	28	prep	28:AM-LOC
31	an	an	DT	_	32	det	_
32	interview	interview	NN	_	30	pobj	_
33	with	with	IN	_	32	prep	_
34	The	the	DT	_	37	det	_
35	Wall	wall	NNP	_	36	nn	_
36	Street	street	NNP	_	37	nn	_
37	Journal	journal	NNP	_	33	pobj	_
38	,	,	,	_	28	punct	_
39	adding	add	VBG	pb=add.01	28	advcl	28:AM-ADV
40	the	the	DT	_	41	det	_
41	offer	offer	NN	_	39	dobj	39:A1=PPT;43:A1=PPT
42	was	be	VBD	_	43	auxpass	_
43	rejected	reject	VBN	pb=reject.01	39	ccomp	39:AM-ADV
44	because	because	IN	_	49	mark	_
45	it	it	PRP	_	49	nsubj	49:A0=PAG
46	"	"	``	_	49	punct	_
47	does	do	VBZ	_	49	aux	_
48	not	not	RB	_	49	neg	49:AM-NEG
49	meet	meet	VB	pb=meet.01	43	advcl	43:AM-CAU
50	the	the	DT	_	51	det	_
51	value	value	NN	_	49	dobj	49:A1=PPT;55:A1=PPT
52	that	that	WDT	p2=IN	55	dobj	55:R-A1
53	we	we	PRP	_	55	nsubj	55:A0=PAG
54	would	would	MD	_	55	aux	55:AM-MOD
55	put	put	VB	pb=put.01	51	rcmod	_
56	on	on	IN	p2=RP	55	prep	55:A2=GOL
57	a	a	DT	_	61	det	_
58	stand	stand	VB	_	61	nn	_
59	-	-	HYPH	_	58	hyph	_
60	alone	alone	RB	p2=RP	58	advmod	_
61	company	company	NN	_	56	pobj	_
62	.	.	.	_	28	punct	_
63	"	"	''	_	28	punct	_

1	The	the	DT	_	2	det	_
2	board	board	NN	_	4	poss	_
3	's	's	POS	_	2	possessive	_
4	decision	decision	NN	_	5	nsubj	5:A1=PPT
5	was	be	VBD	pb=be.01	14	ccomp	14:A1=PPT
6	unanimous	unanimous	JJ	_	5	acomp	5:A2=PRD
7	,	,	,	_	14	punct	_
8	a	a	DT	_	9	det	_
9	person	person	NN	_	14	nsubj	14:A0
10	close	close	JJ	_	9	amod	_
11	to	to	IN	_	10	prep	_
12	the	the	DT	_	13	det	_
13	company	company	NN	_	11	pobj	_
14	said	say	VBD	pb=say.01	0	root	_
15	.	.	.	_	14	punct	_

1	Mr.	mr.	NNP	_	2	nn	_
2	Johansson	johansson	NNP	_	3	nsubj	3:A0=PAG;19:A0=PAG
3	highlighted	highlight	VBD	pb=highlight.01	0	root	_
4	concerns	concern	NNS	_	3	dobj	3:A1=PPT
5	over	over	IN	_	4	prep	_
6	the	the	DT	_	9	det	_
7	U.S.	u.s.	NNP	_	9	nn	_
8	tax	tax	NN	_	9	nn	_
9	implications	implication	NNS	_	5	pobj	_
10	of	of	IN	_	9	prep	_
11	a	a	DT	_	12	det	_
12	deal	deal	NN	_	10	pobj	_
13	as	as	IN	_	12	prep	_
14	a	a	DT	_	17	det	_
15	key	key	JJ	p2=NN	17	amod	_
16	execution	execution	NN	_	17	nn	_
17	risk	risk	NN	_	13	pobj	_
18	,	,	,	_	3	punct	_
19	playing	play	VBG	pb=play.07	3	advcl	3:AM-ADV
20	down	down	RP	_	19	prt	19:C-V
21	U.K.	u.k.	NNP	_	23	nn	_
22	regulatory	regulatory	JJ	_	23	amod	_
23	risk	risk	NN	_	19	dobj	19:A1=PPT
24	.	.	.	_	3	punct	_

1	"	"	``	_	11	punct	_
2	In	in	IN	_	11	prep	11:AM-TMP
3	the	the	DT	_	4	det	_
4	end	end	NN	_	2	pobj	_
5	,	,	,	_	11	punct	_
6	in	in	IN	_	11	prep	11:AM-LOC
7	the	the	DT	_	8	det	_
8	U.K.	u.k.	NNP	_	6	pobj	_
9	,	,	,	_	11	punct	_
10	it	it	PRP	_	11	nsubj	11:A1=PPT
11	is	be	VBZ	pb=be.01	26	ccomp	26:A1=PPT
12	for	for	IN	_	15	mark	_
13	shareholders	shareholder	NNS	_	15	nsubj	15:A0=PAG
14	to	to	TO	_	15	aux	_
15	decide	decide	VB	pb=decide.01	11	advcl	11:A2=PRD
16	whether	whether	IN	_	18	complm	_
17	they	they	PRP	_	18	nsubj	18:A0=PAG;20:A0=PAG
18	want	want	VBP	pb=want.01	15	ccomp	15:A1=PPT
19	to	to	TO	_	20	aux	_
20	sell	sell	VB	pb=sell.01	18	xcomp	18:A1=PPT
21	their	their	PRP$	_	22	poss	_
22	company	company	NN	_	20	dobj	20:A1=PPT
23	,	,	,	_	26	punct	_
24	"	"	''	_	26	punct	_
25	he	he	PRP	_	26	nsubj	26:A0
26	said	say	VBD	pb=say.01	0	root	_
27	.	.	.	_	26	punct	_

1	Pfizer	pfizer	NNP	p2=NN	3	nsubj	3:A0=PAG;5:A0=PAG
2	is	be	VBZ	_	3	aux	_
3	seeking	seek	VBG	pb=seek.01	0	root	_
4	to	to	TO	_	5	aux	_
5	acquire	acquire	VB	pb=acquire.01	3	xcomp	3:A1=PPT
6	AstraZeneca	astrazeneca	NNP	_	5	dobj	5:A1=PPT
7	in	in	IN	_	5	prep	5:AM-MNR
8	a	a	DT	_	13	det	_
9	so	so	RB	_	11	hmod	_
10	-	-	HYPH	_	11	hyph	_
11	called	call	VBN	_	13	amod	_
12	inversion	inversion	NN	p2=JJ	13	nn	_
13	deal	deal	NN	_	7	pobj	_
14	,	,	,	_	13	punct	_
15	a	a	DT	_	16	det	_
16	kind	kind	NN	_	13	appos	24:AM-LOC
17	of	of	IN	_	16	prep	_
18	merger	merger	NN	_	17	pobj	_
19	in	in	IN	_	24	prep	24:R-AM-LOC
20	which	which	WDT	_	19	pobj	_
21	a	a	DT	_	23	det	_
22	U.S.	u.s.	NNP	_	23	nn	_
23	company	company	NN	_	24	nsubj	24:A0=PAG
24	changes	change	VBZ	pb=change.01	16	rcmod	_
25	its	its	PRP$	_	26	poss	_
26	domicile	domicile	NN	p2=NNP	24	dobj	24:A1=PPT
27	to	to	IN	_	24	prep	24:A2=PRD
28	the	the	DT	_	33	det	_
29	relatively	relatively	RB	p2=JJ	32	advmod	_
30	tax	tax	NN	_	32	hmod	_
31	-	-	HYPH	_	32	hyph	_
32	friendly	friendly	JJ	_	33	amod	_
33	home	home	NN	_	27	pobj	_
34	of	of	IN	_	33	prep	_
35	its	its	PRP$	_	36	poss	_
36	target	target	NN	_	34	pobj	_
37	.	.	.	_	3	punct	_

1	The	the	DT	_	4	det	_
2	U.S.	u.s.	NNP	_	4	nn	_
3	drug	drug	NN	_	4	nn	_
4	giant	giant	NN	_	5	nsubj	5:A0;7:A0;14:A0=PAG
5	hopes	hope	VBZ	pb=hope.01	0	root	_
6	to	to	TO	_	7	aux	_
7	reduce	reduce	VB	pb=reduce.01	5	xcomp	5:A1=PPT
8	its	its	PRP$	_	11	poss	_
9	annual	annual	JJ	_	11	amod	_
10	tax	tax	NN	_	11	nn	_
11	bill	bill	NN	_	7	dobj	7:A1=PPT
12	sharply	sharply	RB	_	7	advmod	7:AM-MNR
13	by	by	IN	_	7	prep	7:A2=EXT
14	changing	change	VBG	pb=change.01	13	pcomp	_
15	its	its	PRP$	_	16	poss	_
16	domicile	domicile	NN	p2=NNS	14	dobj	14:A1=PPT
17	to	to	IN	_	14	prep	14:A2=PRD
18	the	the	DT	_	19	det	_
19	U.K.	u.k.	NNP	_	17	pobj	_
20	,	,	,	_	5	punct	_
21	but	but	CC	_	5	cc	_
22	U.S.	u.s.	NNP	_	23	nn	_
23	lawmakers	lawmaker	NNS	_	25	nsubj	25:A0
24	have	have	VBP	_	25	aux	_
25	said	say	VBN	pb=say.01	5	conj	_
26	they	they	PRP	_	28	nsubj	28:A0=PAG;30:A0=PAG
27	might	might	MD	_	28	aux	28:AM-MOD
28	seek	seek	VB	pb=seek.01	25	ccomp	25:A1=PPT
29	to	to	TO	_	30	aux	_
30	discourage	discourage	VB	pb=discourage.01	28	xcomp	28:A1=PPT
31	further	far	JJ	p2=RB	32	amod	_
32	inversions	inversion	NNS	_	30	dobj	30:A1=PPT
33	.	.	.	_	25	punct	_

1	Mr.	mr.	NNP	_	2	nn	_
2	Johansson	johansson	NNP	_	3	nsubj	3:A0
3	said	say	VBD	pb=say.01	0	root	_
4	he	he	PRP	_	5	nsubj	5:A0=PAG
5	had	have	VBD	pb=have.03	3	ccomp	3:A1=PPT
6	"	"	``	_	8	punct	_
7	great	great	JJ	_	8	amod	_
8	respect	respect	NN	_	5	dobj	5:A1=PPT
9	"	"	''	_	8	punct	_
10	for	for	IN	_	8	prep	_
11	the	the	DT	_	12	det	_
12	plurality	plurality	NN	_	10	pobj	_
13	of	of	IN	_	12	prep	_
14	shareholder	shareholder	NN	_	15	nn	_
15	views	view	NNS	p2=VBZ	13	pobj	_
16	on	on	IN	_	15	prep	_
17	a	a	DT	_	18	det	_
18	deal	deal	NN	_	16	pobj	_
19	.	.	.	_	3	punct	_

1	The	the	DT	_	2	det	_
2	board	board	NN	_	4	nsubj	6:A0=PAG;4:A1=PPT
3	will	will	MD	_	4	aux	4:AM-MOD
4	continue	continue	VB	pb=continue.01	18	ccomp	18:A1=PPT
5	to	to	TO	_	6	aux	_
6	meet	meet	VB	pb=meet.03	4	xcomp	4:C-A1
7	with	with	IN	_	6	prep	6:A1=COM
8	investors	investor	NNS	_	7	pobj	_
9	Monday	monday	NNP	_	6	npadvmod	6:AM-TMP
10	,	,	,	_	4	punct	_
11	as	as	IN	_	13	mark	_
12	it	it	PRP	_	13	nsubj	13:A0=PAG
13	did	do	VBD	pb=do.02	4	advcl	_
14	last	last	JJ	_	15	amod	_
15	week	week	NN	_	13	npadvmod	13:AM-TMP
16	,	,	,	_	18	punct	_
17	he	he	PRP	_	18	nsubj	18:A0=PAG
18	added	add	VBD	pb=add.01	0	root	_
19	.	.	.	_	18	punct	_

1	Large	large	JJ	_	2	amod	_
2	investors	investor	NNS	_	12	nsubj	12:A0=PAG
3	Aberdeen	aberdeen	NNP	_	6	nn	_
4	Asset	asset	NNP	_	6	nn	_
5	Management	management	NNP	_	6	nn	_
6	PLC	plc	NNP	_	2	appos	_
7	and	and	CC	_	6	cc	_
8	Investor	investor	NNP	p2=NN	9	nn	_
9	AB	ab	NNP	_	6	conj	_
10	have	have	VBP	_	12	aux	_
11	previously	previously	RB	_	12	advmod	12:AM-TMP
12	voiced	voice	VBN	pb=voice.01	0	root	_
13	public	public	JJ	_	14	amod	_
14	support	support	NN	_	12	dobj	12:A1=PPT
15	for	for	IN	_	14	prep	_
16	the	the	DT	_	18	det	_
17	AstraZeneca	astrazeneca	NNP	_	18	nn	_
18	board	board	NN	_	15	pobj	_
19	.	.	.	_	12	punct	_

1	A	a	DT	_	2	det	_
2	spokesman	spokesman	NN	_	5	nsubj	5:A0
3	for	for	IN	_	2	prep	_
4	Aberdeen	aberdeen	NNP	_	3	pobj	_
5	said	say	VBD	pb=say.01	0	root	_
6	Monday	monday	NNP	_	5	npadvmod	5:AM-TMP
7	the	the	DT	_	8	det	_
8	company	company	NN	_	10	nsubj	12:A0=PAG;17:A0=PAG;10:A1=PPT
9	was	be	VBD	_	10	aux	_
10	continuing	continue	VBG	pb=continue.01	5	ccomp	5:A1=PPT
11	to	to	TO	_	12	aux	_
12	meet	meet	VB	pb=meet.03	10	xcomp	10:C-A1
13	with	with	IN	_	12	prep	12:A1=COM
14	both	both	DT	_	15	det	_
15	companies	company	NNS	_	13	pobj	_
16	to	to	TO	_	17	aux	_
17	discuss	discuss	VB	pb=discuss.01	12	advcl	12:AM-PRP
18	the	the	DT	_	19	det	_
19	situation	situation	NN	_	17	dobj	17:A1=PPT
20	.	.	.	_	5	punct	_

1	Investor	investor	NN	p2=NNP	2	nn	_
2	AB	ab	NNP	p2=NN	6	nsubjpass	6:A1=PPT
3	could	could	MD	_	6	aux	6:AM-MOD
4	n't	not	RB	_	6	neg	6:AM-NEG
5	be	be	VB	_	6	auxpass	_
6	reached	reach	VBN	pb=reach.02	0	root	_
7	for	for	IN	_	6	prep	6:AM-PNC
8	comment	comment	NN	_	7	pobj	_
9	.	.	.	_	6	punct	_

1	"	"	``	_	5	punct	_
2	They	they	PRP	_	5	nsubj	5:A0=PAG;8:A0=PAG
3	can	can	MD	_	5	aux	5:AM-MOD;8:AM-MOD
4	either	either	CC	p2=RB	5	preconj	_
5	accept	accept	VB	pb=accept.01	17	ccomp	17:A1=PPT
6	it	it	PRP	_	5	dobj	5:A1=PPT
7	or	or	CC	_	5	cc	_
8	reject	reject	VB	p2=VBP|pb=reject.01	5	conj	_
9	it	it	PRP	_	8	dobj	8:A1=PPT
10	,	,	,	_	17	punct	_
11	"	"	''	p2=``	17	punct	_
12	Pfizer	pfizer	NNP	_	13	nn	_
13	Chief	chief	NNP	_	16	nn	_
14	Executive	executive	NNP	_	16	nn	_
15	Ian	ian	NNP	_	16	nn	_
16	Read	read	NNP	_	17	nsubj	17:A0
17	said	say	VBD	pb=say.01	0	root	_
18	Sunday	sunday	NNP	_	17	npadvmod	17:AM-TMP
19	in	in	IN	_	17	prep	17:AM-LOC
20	an	an	DT	_	21	det	_
21	interview	interview	NN	_	19	pobj	_
22	with	with	IN	_	21	prep	_
23	The	the	DT	_	26	det	_
24	Wall	wall	NNP	_	25	nn	_
25	Street	street	NNP	_	26	nn	_
26	Journal	journal	NNP	_	22	pobj	_
27	.	.	.	_	17	punct	_

1	"	"	``	_	3	punct	_
2	They	they	PRP	_	3	nsubj	_
3	have	have	VBP	_	4	aux	_
4	until	until	IN	_	0	root	_
5	the	the	DT	_	6	det	_
6	26th	#ord#	NN	_	4	pobj	_
7	of	of	IN	_	6	prep	_
8	May	may	NNP	_	7	pobj	_
9	.	.	.	_	3	punct	_
10	"	"	''	_	3	punct	_

1	After	after	IN	_	11	prep	11:AM-TMP
2	the	the	DT	_	3	det	_
3	rejection	rejection	NN	_	1	pobj	_
4	,	,	,	_	11	punct	_
5	the	the	DT	_	8	det	_
6	U.K.	u.k.	NNP	_	8	nn	_
7	drug	drug	NN	_	8	nn	_
8	company	company	NN	_	10	poss	_
9	's	's	POS	_	8	possessive	_
10	shares	share	NNS	_	11	nsubj	11:A1;22:A1=PPT
11	slumped	slump	VBD	p2=VBN|pb=slump.01	0	root	_
12	as	as	RB	_	15	advmod	_
13	much	much	JJ	p2=RB	15	amod	_
14	as	as	IN	_	15	quantmod	_
15	15	0	CD	_	16	num	_
16	%	%	NN	_	11	dobj	11:A2=EXT
17	in	in	IN	_	11	prep	11:AM-LOC
18	early	early	JJ	_	20	amod	_
19	London	london	NNP	_	20	nn	_
20	trading	trading	NN	_	17	pobj	_
21	before	before	IN	_	11	prep	11:AM-TMP
22	recovering	recover	VBG	pb=recover.01	21	pcomp	_
23	somewhat	somewhat	RB	_	22	advmod	22:AM-EXT
24	.	.	.	_	11	punct	_

1	AstraZeneca	astrazeneca	NNP	p2=NN	2	nn	_
2	shares	share	NNS	_	3	nsubj	3:A1=PPT
3	were	be	VBD	pb=be.01	0	root	_
4	lately	lately	RB	_	3	advmod	3:AM-TMP
5	down	down	RB	p2=IN	3	advmod	3:A2=PRD
6	9.4	0	CD	_	7	num	_
7	%	%	NN	_	5	npadvmod	_
8	to	to	IN	p2=TO	5	prep	_
9	GBP	gbp	NNP	p2=$	8	pobj	_
10	43.68	0	CD	_	9	num	_
11	.	.	.	_	3	punct	_

1	"	"	``	_	3	punct	_
2	They	they	PRP	_	3	nsubj	5:A0=PAG;3:A1=PPT
3	seem	seem	VBP	pb=seem.01	18	ccomp	18:A1=PPT
4	to	to	TO	_	5	aux	_
5	have	have	VB	pb=have.03	3	xcomp	3:C-A1
6	quite	quite	PDT	p2=RB	9	predet	_
7	a	a	DT	_	9	det	_
8	punchy	punchy	JJ	_	9	amod	_
9	view	view	NN	_	5	dobj	5:A1=PPT
10	of	of	IN	_	9	prep	_
11	what	what	WP	_	14	attr	14:R-A2
12	their	their	PRP$	_	13	poss	_
13	pipeline	pipeline	NN	_	14	nsubj	14:A1=PPT
14	is	be	VBZ	pb=be.01	10	pcomp	_
15	worth	worth	JJ	_	14	acomp	14:A2=PRD
16	,	,	,	_	18	punct	_
17	"	"	''	_	18	punct	_
18	said	say	VBD	pb=say.01	0	root	_
19	Dan	dan	NNP	_	20	nn	_
20	Mahony	mahony	NNP	_	18	nsubj	18:A0;37:A0=PAG
21	,	,	,	_	20	punct	_
22	a	a	DT	_	27	det	_
23	health	health	NN	_	25	hmod	_
24	-	-	HYPH	_	25	hyph	_
25	care	care	NN	_	27	nn	_
26	fund	fund	NN	_	27	nn	_
27	manager	manager	NN	_	20	appos	_
28	at	at	IN	_	27	prep	_
29	Polar	polar	NNP	_	30	nn	_
30	Capital	capital	NNP	p2=NN	28	pobj	_
31	and	and	CC	_	27	cc	_
32	a	a	DT	_	35	det	_
33	small	small	JJ	_	35	amod	_
34	AstraZeneca	astrazeneca	NNP	_	35	nn	_
35	investor	investor	NN	_	27	conj	_
36	,	,	,	_	18	punct	_
37	adding	add	VBG	pb=add.01	18	advcl	18:AM-ADV
38	he	he	PRP	_	39	nsubj	39:A1=PPT
39	was	be	VBD	pb=be.01	37	ccomp	37:A1=PPT
40	frustrated	frustrated	JJ	p2=VBN	39	acomp	39:A2=PRD
41	with	with	IN	_	40	prep	_
42	the	the	DT	_	43	det	_
43	rejection	rejection	NN	_	41	pobj	_
44	.	.	.	_	18	punct	_

1	"	"	``	_	5	punct	_
2	I	I	PRP	_	5	nsubj	5:A0
3	do	do	VBP	_	5	aux	_
4	n't	not	RB	_	5	neg	5:AM-NEG
5	think	think	VB	pb=think.01	0	root	_
6	GBP	gbp	NNP	_	8	nsubj	8:A1=PPT
7	55	0	CD	_	6	num	_
8	was	be	VBD	pb=be.01	5	ccomp	5:A1=PPT
9	too	too	RB	_	10	advmod	_
10	unreasonable	unreasonable	JJ	_	8	acomp	8:A2=PRD
11	,	,	,	_	8	punct	_
12	to	to	TO	_	13	aux	_
13	knock	knock	VB	pb=knock.01	8	advcl	8:AM-ADV
14	it	it	PRP	_	13	dobj	13:A1=PPT
15	completely	completely	RB	_	13	advmod	13:AM-EXT
16	out	out	IN	_	13	prep	13:A2=MNR
17	of	of	IN	_	16	prep	_
18	the	the	DT	_	19	det	_
19	park	park	NN	_	17	pobj	_
20	again	again	RB	_	13	advmod	13:AM-TMP
21	.	.	.	_	5	punct	_
22	"	"	''	_	5	punct	_

1	Mr.	mr.	NNP	_	2	nn	_
2	Mahony	mahony	NNP	_	3	nsubj	3:A0
3	said	say	VBD	pb=say.01	0	root	_
4	he	he	PRP	_	5	nsubj	5:A0=PAG
5	doubted	doubt	VBD	pb=doubt.01	3	ccomp	3:A1=PPT
6	another	another	DT	_	7	det	_
7	bidder	bidder	NN	_	9	nsubj	9:A0=PPT
8	would	would	MD	_	9	aux	9:AM-MOD
9	emerge	emerge	VB	pb=emerge.01	5	ccomp	5:A1=PPT
10	,	,	,	_	9	punct	_
11	and	and	CC	_	9	cc	_
12	that	that	IN	_	16	mark	_
13	he	he	PRP	_	16	nsubj	16:A0
14	did	do	VBD	_	16	aux	_
15	n't	not	RB	_	16	neg	16:AM-NEG
16	see	see	VB	pb=see.01	9	conj	_
17	Pfizer	pfizer	NNP	_	18	nsubj	18:A1=PPT
18	returning	return	VBG	pb=return.01	16	ccomp	16:A1
19	with	with	IN	_	18	prep	18:AM-MNR
20	another	another	DT	_	21	det	_
21	offer	offer	NN	_	19	pobj	_
22	.	.	.	_	3	punct	_

1	"	"	``	_	3	punct	_
2	I	I	PRP	_	3	nsubj	3:A0=PAG
3	get	get	VBP	pb=get.01	13	ccomp	13:A1=PPT
4	the	the	DT	_	5	det	_
5	impression	impression	NN	_	3	dobj	3:A1=PPT
6	Pfizer	pfizer	NNP	p2=NN	9	nsubj	9:A0=PPT
7	will	will	MD	_	9	aux	9:AM-MOD
8	just	just	RB	_	9	advmod	9:AM-ADV
9	walk	walk	VB	pb=walk.01	5	ccomp	_
10	,	,	,	_	13	punct	_
11	"	"	''	p2=``	13	punct	_
12	he	he	PRP	_	13	nsubj	13:A0
13	said	say	VBD	pb=say.01	0	root	_
14	.	.	.	_	13	punct	_

1	"	"	``	_	3	punct	_
2	I	I	PRP	_	3	nsubj	3:A0
3	think	think	VBP	pb=think.01	0	root	_
4	a	a	DT	_	5	det	_
5	lot	lot	NN	_	12	nsubjpass	12:A1=PPT
6	of	of	IN	_	5	prep	_
7	these	these	DT	_	8	det	_
8	companies	company	NNS	_	6	pobj	_
9	are	be	VBP	_	12	auxpass	_
10	more	more	RBR	p2=JJR	11	advmod	_
11	financially	financially	RB	_	12	advmod	12:AM-MNR
12	disciplined	discipline	VBN	p2=JJ|pb=discipline.01	3	ccomp	3:A1=PPT
13	than	than	IN	_	15	mark	_
14	they	they	PRP	_	15	nsubj	15:A1=PPT
15	were	be	VBD	pb=be.01	12	advcl	_
16	15	0	CD	_	17	num	_
17	years	year	NNS	_	18	npadvmod	_
18	ago	ago	RB	_	15	advmod	15:AM-TMP
19	.	.	.	_	3	punct	_
20	"	"	''	_	3	punct	_

1	Mr.	mr.	NNP	_	2	nn	_
2	Mahony	mahony	NNP	_	3	nsubj	3:A0=PAG
3	added	add	VBD	pb=add.01	0	root	_
4	that	that	IN	_	7	complm	_
5	AstraZeneca	astrazeneca	NNP	_	6	nn	_
6	management	management	NN	_	7	nsubj	7:A1=PPT
7	was	be	VBD	pb=be.01	3	ccomp	3:A1=PPT
8	now	now	RB	_	7	advmod	7:AM-TMP
9	in	in	IN	_	7	prep	7:A2=PRD
10	a	a	DT	_	12	det	_
11	difficult	difficult	JJ	_	12	amod	_
12	position	position	NN	_	9	pobj	_
13	if	if	IN	_	15	mark	_
14	it	it	PRP	_	15	nsubj	17:A0=PAG;15:A1=PAG
15	failed	fail	VBD	pb=fail.01	7	advcl	7:AM-ADV
16	to	to	TO	_	17	aux	_
17	live	live	VB	pb=live.04	15	xcomp	15:A2=PPT
18	up	up	RP	_	17	prt	17:C-V
19	to	to	IN	p2=TO	17	prep	17:A1=PPT
20	ambitious	ambitious	JJ	_	23	amod	_
21	new	new	JJ	_	23	amod	_
22	sales	sale	NNS	_	23	nn	_
23	targets	target	NNS	p2=VBZ	19	pobj	_
24	in	in	IN	_	17	prep	17:AM-TMP
25	coming	come	VBG	pb=come.01	26	amod	_
26	years	year	NNS	_	24	pobj	25:A1=PPT
27	.	.	.	_	3	punct	_

1	"	"	``	p2=''	7	punct	_
2	The	the	DT	_	5	det	_
3	next	next	JJ	_	5	amod	_
4	three	#crd#	CD	_	5	num	_
5	years	year	NNS	_	7	nsubj	9:A1=PPT
6	are	be	VBP	_	7	aux	_
7	going	go	VBG	pb=go.04	0	root	_
8	to	to	TO	_	9	aux	_
9	be	be	VB	pb=be.01	7	xcomp	_
10	really	really	RB	_	11	advmod	_
11	tricky	tricky	JJ	_	9	acomp	9:A2=PRD
12	for	for	IN	_	9	prep	9:AM-GOL
13	them	them	PRP	_	12	pobj	_
14	as	as	IN	_	20	mark	_
15	[	[	-LRB-	_	19	punct	_
16	cholesterol	cholesterol	NN	_	17	nn	_
17	drug	drug	NN	_	19	nn	_
18	]	]	-RRB-	_	17	punct	_
19	Crestor	crestor	NNP	p2=NN	20	nsubj	20:A1=PPT
20	goes	go	VBZ	pb=go.16	9	advcl	9:AM-TMP
21	off	off	RP	p2=IN	20	prep	20:C-V
22	patent	patent	NN	_	21	pobj	_
23	.	.	.	_	7	punct	_
24	"	"	''	_	7	punct	_

1	Both	both	DT	_	2	det	_
2	companies	company	NNS	_	4	nsubj	4:A0=PAG;9:A0=PAG
3	are	be	VBP	_	4	aux	_
4	grappling	grapple	VBG	pb=grapple.01	0	root	_
5	with	with	IN	_	4	prep	4:A1=PPT
6	aging	age	VBG	pb=age.01	7	amod	_
7	portfolios	portfolio	NNS	_	5	pobj	6:A1=PPT
8	and	and	CC	_	4	cc	_
9	losing	lose	VBG	pb=lose.02	4	conj	_
10	billions	#crd#	NNS	_	9	dobj	9:A1=PPT
11	of	of	IN	_	10	prep	_
12	dollars	dollar	NNS	_	11	pobj	_
13	in	in	IN	_	9	prep	9:AM-LOC
14	sales	sale	NNS	_	13	pobj	_
15	to	to	IN	_	14	prep	_
16	generic	generic	JJ	_	17	amod	_
17	competition	competition	NN	_	15	pobj	_
18	.	.	.	_	4	punct	_

1	Each	each	DT	_	2	det	_
2	company	company	NN	_	3	nsubj	3:A0=PAG
3	posted	post	VBD	pb=post.01	0	root	_
4	a	a	DT	_	7	det	_
5	6	0	CD	_	6	num	_
6	%	%	NN	_	7	nn	_
7	drop	drop	NN	_	3	dobj	3:A1=PPT
8	in	in	IN	_	7	prep	_
9	sales	sale	NNS	_	8	pobj	_
10	last	last	JJ	_	11	amod	_
11	year	year	NN	_	7	npadvmod	_
12	.	.	.	_	3	punct	_

1	Pfizer	pfizer	NNP	_	3	poss	_
2	's	's	POS	_	1	possessive	_
3	sales	sale	NNS	_	4	nsubj	4:A1=PPT
4	fell	fall	VBD	pb=fall.01	0	root	_
5	to	to	IN	_	4	prep	4:A4=GOL
6	$	$	$	_	8	quantmod	_
7	51.6	0	CD	_	8	number	_
8	billion	#crd#	CD	_	5	pobj	_
9	,	,	,	_	4	punct	_
10	while	while	IN	_	13	mark	_
11	AstraZeneca	astrazeneca	NNP	_	13	nsubj	13:A0=PAG
12	's	's	POS	p2=VBZ	11	possessive	_
13	dropped	drop	VBD	p2=VBN|pb=drop.01	4	advcl	4:AM-ADV
14	to	to	IN	_	13	prep	13:A4=LOC
15	$	$	$	_	17	quantmod	_
16	25.7	0	CD	_	17	number	_
17	billion	#crd#	CD	_	14	pobj	_
18	.	.	.	_	4	punct	_

1	AstraZeneca	astrazeneca	NNP	p2=JJ	2	nn	_
2	shares	share	NNS	_	3	nsubj	9:A0;3:A1=PPT
3	closed	close	VBD	pb=close.02	0	root	_
4	Friday	friday	NNP	_	3	npadvmod	3:AM-TMP
5	at	at	IN	_	3	prep	3:AM-EXT
6	GBP	gbp	NNP	_	5	pobj	_
7	48.23	0	CD	p2=NNP	6	num	_
8	,	,	,	_	3	punct	_
9	valuing	value	VBG	pb=value.01	3	advcl	3:AM-ADV
10	the	the	DT	_	11	det	_
11	company	company	NN	_	9	dobj	9:A1
12	at	at	IN	_	9	prep	9:A2=PRD
13	GBP	gbp	NNP	p2=$	15	quantmod	_
14	60.89	0	CD	_	15	number	_
15	billion	#crd#	CD	_	12	pobj	_
16	.	.	.	_	3	punct	_

1	Jonathan	jonathan	NNP	_	2	nn	_
2	Rockoff	rockoff	NNP	_	6	nsubj	6:A0=PAG
3	and	and	CC	_	2	cc	_
4	Ian	ian	NNP	_	5	nn	_
5	Walker	walker	NNP	_	2	conj	_
6	contributed	contribute	VBD	pb=contribute.01	0	root	_
7	to	to	IN	_	6	prep	6:A2=GOL
8	this	this	DT	_	9	det	_
9	article	article	NN	_	7	pobj	_
10	.	.	.	_	6	punct	_

1	An	an	DT	_	2	det	_
2	error	error	NN	_	4	nsubj	4:A1=PPT
3	has	have	VBZ	_	4	aux	_
4	occured	occur	VBN	pb=occur.01	0	root	_
5	and	and	CC	_	4	cc	_
6	your	your	PRP$	_	7	poss	_
7	email	email	NN	_	11	nsubjpass	11:A1=PPT
8	has	have	VBZ	_	11	aux	_
9	not	not	RB	_	11	neg	11:AM-NEG
10	been	be	VBN	_	11	auxpass	_
11	sent	send	VBN	pb=send.01	4	conj	_
12	.	.	.	_	11	punct	_

1	•	•	NFP	p2=JJ	2	punct	_
2	Seperate	seperate	VB	pb=seperate.01	0	root	_
3	multiple	multiple	JJ	_	4	amod	_
4	addresses	address	NNS	_	2	dobj	2:A1
5	with	with	IN	_	2	prep	2:A2
6	Commas	commas	NNP	p2=NNS	5	pobj	_
7	.	.	.	_	2	punct	_

1	•	•	:	p2=,	3	punct	_
2	Must	must	MD	_	3	aux	3:AM-MOD
3	enter	enter	VB	pb=enter.01	0	root	_
4	an	an	DT	_	6	det	_
5	email	email	NN	_	6	nn	_
6	address	address	NN	_	3	dobj	3:A1=LOC
7	.	.	.	_	3	punct	_

1	•	•	``	p2=UH	4	punct	_
2	You	you	PRP	_	4	nsubj	4:A0=PPT;10:A0=PAG
3	must	must	MD	_	4	aux	4:AM-MOD
4	enter	enter	VB	pb=enter.01	0	root	_
5	the	the	DT	_	7	det	_
6	verification	verification	NN	_	7	nn	_
7	code	code	NN	_	4	dobj	4:A1=LOC
8	below	below	RB	p2=IN	4	advmod	4:AM-MNR
9	to	to	TO	_	10	aux	_
10	send	send	VB	pb=send.01	4	advcl	4:AM-PRP
11	.	.	.	_	4	punct	_

1	•	•	HYPH	p2=``	2	nn	_
2	Invalid	invalid	NNP	p2=JJ	3	nn	_
3	entry	entry	NN	_	6	dep	_
4	:	:	:	_	6	punct	_
5	Please	please	UH	p2=VB	6	intj	6:AM-DIS
6	type	type	VB	pb=type.01	0	root	_
7	the	the	DT	_	9	det	_
8	verification	verification	NN	_	9	nn	_
9	code	code	NN	_	6	dobj	6:A1=PPT
10	again	again	RB	_	6	advmod	6:AM-TMP
11	.	.	.	_	6	punct	_

